These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32953852)

  • 1. Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients.
    Zeng J; Xie MH; Yang J; Chao SW; Xu EL
    World J Clin Cases; 2020 Sep; 8(17):3763-3773. PubMed ID: 32953852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
    Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal and Fetal Outcome in Pregnant Women With Critical COVID-19 Treated With Tocilizumab in a Tertiary Care Hospital in Dubai.
    Isaac B; Hazari K; Harb DK; Mallick AK; Abdelkareem W; Ammar A; Gergawi T; Saeed Al Zahmi E; Khamis AH
    Cureus; 2023 Jan; 15(1):e34395. PubMed ID: 36874696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tocilizumab in COVID-19 patients.
    Zheng KL; Xu Y; Guo YF; Diao L; Kong XY; Wan XJ; Zhao F; Ning FZ; Wang LB; Qiao F; Zhao JM; Zhou JH; Zhong YQ; Wu SX; Chen Y; Jin G; Dong YC
    Aging (Albany NY); 2020 Oct; 12(19):18878-18888. PubMed ID: 33031060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers.
    Nasa P; Singh A; Upadhyay S; Bagadia S; Polumuru S; Shrivastava PK; Sankar R; Vijayan L; Soliman MA; Ali A; Patidar S
    Indian J Crit Care Med; 2020 Sep; 24(9):771-776. PubMed ID: 33132558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report.
    Xu Q; Wang T; Lu W
    Open Life Sci; 2021; 16(1):809-814. PubMed ID: 34485700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Study of Cytokine Storm Treatment in Patients with COVID-19 Pneumonia Using Immunomodulators.
    Marc F; Moldovan CM; Hoza A; Magheru S; Ciavoi G; Farcas DM; Sachelarie L; Calin G; Romila L; Damir D; Naum AG
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35629072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration Timing and Efficacy of Tocilizumab in Patients With COVID-19 and Elevated IL-6.
    Li P; Lu Z; Li Q; Wang Z; Guo Y; Cai C; Wang S; Liu P; Su X; Huang Y; Dong Y; Qiu W; Ling Y; Yarmus L; Luo F; Zeng L; Bai C; Zhang W
    Front Mol Biosci; 2021; 8():651662. PubMed ID: 33937333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia.
    Keiffer G; French Z; Wilde L; Filicko-O'Hara J; Gergis U; Binder AF
    Front Oncol; 2020; 10():562625. PubMed ID: 33072589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19.
    Hashimoto S; Yoshizaki K; Uno K; Kitajima H; Arai T; Tamura Y; Morishita H; Matsuoka H; Han Y; Minamoto S; Hirashima T; Yamada T; Kashiwa Y; Kameda M; Yamaguchi S; Tsuchihashi Y; Iwahashi M; Nakayama E; Shioda T; Nagai T; Tanaka T
    Front Med (Lausanne); 2021; 8():734838. PubMed ID: 34631752
    [No Abstract]   [Full Text] [Related]  

  • 11. Coagulopathy as a Prodrome of Cytokine Storm in COVID-19-Infected Patients.
    Guo H; Sheng Y; Li W; Li F; Xie Z; Li J; Zhu Y; Geng J; Liu G; Wang L; Li J; Wang F
    Front Med (Lausanne); 2020; 7():572989. PubMed ID: 33195321
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19.
    Douedi S; Chaudhri M; Miskoff J
    Ann Thorac Med; 2020; 15(3):171-173. PubMed ID: 32831940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients.
    Wang Y; Chen Y; Zhou X
    Can J Infect Dis Med Microbiol; 2022; 2022():6375870. PubMed ID: 35308307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab and liver injury in patients with COVID-19.
    Serviddio G; Villani R; Stallone G; Scioscia G; Foschino-Barbaro MP; Lacedonia D
    Therap Adv Gastroenterol; 2020; 13():1756284820959183. PubMed ID: 33101458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Clinical and Laboratory Response to Interleukin-6 Receptor Blockade With Tocilizumab in 89 Hospitalized Patients With COVID-19 Pneumonia.
    Fomina DS; Lysenko MA; Beloglazova IP; Mutovina ZY; Poteshkina NG; Samsonova IV; Kruglova TS; Chernov AA; Karaulov AV
    Pathog Immun; 2020; 5(1):327-341. PubMed ID: 33089038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report.
    Kai Y; Matsuda M; Suzuki K; Kasamatsu T; Kajita A; Uno K; Muro S
    Cureus; 2022 Mar; 14(3):e23411. PubMed ID: 35481309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the First 102 Severe COVID-19 Cases Treated With Convalescent Plasma or Tocilizumab or Both in Al-Nahdha Hospital, Oman.
    Al Harthi S; Osali MA; Kindi NA; Kharusi ZA; Qasabi SA; Hinai MA; Ghafri TA
    Health Serv Res Manag Epidemiol; 2021; 8():2333392820986639. PubMed ID: 33623809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
    Mehta Y; Dixit SB; Zirpe KG; Ansari AS
    Indian J Crit Care Med; 2020 Jun; 24(6):429-434. PubMed ID: 32863636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of influencing factors on the efficacy of mechanical ventilation in severe and critical COVID-19 patients.
    Zeng J; Qi XX; Cai WW; Pan YP; Xie Y
    World J Clin Cases; 2021 Nov; 9(31):9481-9490. PubMed ID: 34877282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab and Cytokine Release Syndrome in COVID-19 Pneumonia: Experience From a Single Center in Pakistan.
    Hassan M; Syed F; Zafar M; Iqbal M; Khan NU; Mushtaq HF; Badshah M
    Cureus; 2021 Dec; 13(12):e20219. PubMed ID: 35004038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.